Supermajority Voting Requirement
A supermajority voting requirement is a charter or bylaw provision that mandates approval of major corporate transactions (typically mergers, asset sales, or liquidations) by 66–80% of shares outstanding, rather than a simple majority. It raises the threshold for hostile-takeover, allowing entrenched management to survive a bid supported by only 51% of shareholders.
Why the supermajority threshold matters
Under Delaware law and most state statutes, a simple majority (50% plus one share) can approve a merger. A supermajority rule raises the bar, so that even if an acquirer owns 51% or 60% of shares, a merger still cannot proceed without additional shareholder support. This fragment of control is enough to block most hostile bids.
The arithmetic is straightforward. An acquirer who owns 51% has a majority but faces a 66% supermajority threshold. To reach 66%, the bidder must secure approval from 15 percentage points of shares held by other shareholders (51% + 15% = 66%). If the acquirer pays a premium but many minority shareholders hold out, hoping for a higher offer or believing the current bid undervalues the firm, the supermajority requirement can collapse the deal.
How it protects incumbents
Supermajority requirements serve incumbent management by making it costly and difficult for an outsider to gain control. Even if a bidder launches a successful tender offer and becomes the largest shareholder, the supermajority rule forces the bidder to negotiate with or persuade minority shareholders. This creates time, expense, and uncertainty—enough friction to deter many acquisition attempts.
A management team aware that a supermajority provision is in place can mount a credible defence. They can argue that the bid is too low, that the company’s long-term prospects are brighter, and that the offer will likely not garner the supermajority support. This can convince wavering shareholders to reject or hold out for a higher price.
In some cases, the supermajority requirement also buys the board time to find a “white knight” (a friendly alternative bidder) or to implement other defences.
The shareholder perspective: trapped value and agency costs
From a shareholder standpoint, supermajority provisions cut both ways. On one hand, they protect shareholders against low-ball bids, forcing an acquirer to make a more attractive offer or abandon the attempt. On the other hand, they can entrench mediocre management indefinitely. If a CEO is underperforming and a rational bid is made at a fair price, the supermajority rule can prevent shareholders from exiting, even if they want to.
This is the classic principal-agent problem in disguise. The board nominally represents shareholders, but supermajority provisions allow the board (and management) to override shareholder preferences. Some shareholders, particularly activists and institutional investors, view supermajority requirements as a governance weakness and campaign to have them repealed.
Others defend them as a hedge against activist pressure or short-termism. A supermajority clause, they argue, ensures that no single large shareholder can dictate corporate strategy and that long-term shareholders retain influence.
Supermajority vs. simple majority
Most corporations operate on a simple-majority rule: 50% plus one vote approves major decisions. This is the default under most state laws. Supermajority provisions are adopted to strengthen defences; they are amendments to the default rule and require shareholder approval themselves.
Interestingly, installing a supermajority requirement often requires a supermajority vote (or at least a vote of the board and shareholders). This creates a chicken-and-egg problem: a company already controlled by an entrenched management can often adopt a supermajority provision, locking itself in further. A company with dispersed ownership may resist such a provision because no actor has enough control to push it through.
Paired with other defenses
Supermajority requirements rarely stand alone. They are typically paired with a poison-pill (a rights plan that dilutes an acquirer’s stake) and a fair-price-provision (which requires all-cash offers at the highest price paid to early sellers). Together, these provisions create a multi-layered deterrent.
A poison pill gives the board time to fight a bid; a fair-price clause ensures all shareholders are treated equally; a supermajority provision gives minority shareholders a veto. An acquirer facing all three faces such high friction that most bids collapse.
Delaware courts and the supermajority defence
Delaware courts (which hear disputes for a large fraction of US public companies) have generally upheld supermajority provisions as legitimate governance tools. However, courts also apply the “Revlon” standard in some cases, requiring the board to act in good faith and seek a fair process if a change of control is inevitable.
A board cannot hide behind supermajority defences to reject a genuinely superior offer without attempting to negotiate or provide shareholders with an exit. The case law is nuanced, but the trend is that supermajority provisions are permissible, though not a blank check for self-interested board behaviour.
Supermajority requirements in practice
Supermajority provisions are common among companies with concentrated ownership (founders, family firms, or those with a controlling shareholder). They are less common among widely held companies, particularly large-cap firms, where institutional investors have grown more vocal in opposing governance provisions that limit their ability to effect change.
Some companies have voluntarily repealed supermajority requirements in recent decades, responding to investor pressure for simpler governance. Others have grandfathered them in, allowing the provision to remain but pledging not to increase the threshold further. A few high-profile companies maintain aggressive supermajority requirements as part of their identity; this can affect their valuation and appeal to certain investors.
See also
Closely related
- Hostile-takeover — acquisition attempt opposed by the target’s board
- Poison-pill — rights plan that dilutes an acquirer’s ownership upon crossing a threshold
- Fair-price-provision — charter requirement to pay all shareholders the highest price paid to any shareholder
- Merger — combination of two companies into one
Wider context
- Acquisition — broad framework for one company buying another
- Tender-offer — public solicitation for shareholders to sell their shares at a stated price
- Voting-rights — shareholder power to elect the board and approve major decisions
- Public-company — corporate structure with dispersed public shareholders